Sharon Begley, 13 April 2017, STAT News, https://www.statnews.com/2017/04/13/crispr-patent-uc-appeal/
UC-Berkeley has filed an appeal with the federal Court of Appeals. UC-Berkeley was joined in its appeal by the University of Vienna and Emmanuelle Charpentier. Previously, the US Patent office had ruled that UC-Berkeley’s and the Broad Institute’s patents did not interfere, leaving them both able to pursue unique patents. In this appeal, UC-Berkeley hopes to establish that the teams led by Doudna and Charpentier were the first to engineer CRISPR/Cas9 in all cell types.